Ask your AI about this

Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:

Connect your AI · Plans and the 7-day free trial (card required)

Buying and selling by quarter

Dollars bought and sold on the open market over the last two years.

$0$200.0K$400.0K$600.0K$800.0KQ3 2025 · Bought: $0Q3 2025 · Sold: $254,112Q3 2025Q4 2025 · Bought: $0Q4 2025 · Sold: $264,479Q4 2025Q1 2026 · Bought: $0Q1 2026 · Sold: $273,654Q1 2026Q2 2026 · Bought: $0Q2 2026 · Sold: $657,520Q2 2026

Bought Sold

By trade date, using the shares and price reported for each trade. Stock grants, option exercises and shares withheld for tax are left out.

Roles

The companies where this person reports as an insider, and their position at each, most recent first.

Roles by company
CompanyRoleLast filed
LGND
Ligand Pharmaceuticals Incorporated
DirectorJun 9, 2026

Roles come from the filings themselves and can change over time.

Latest open-market trades

Purchases and sales at every company, most recent filing first.

Latest insider trades
How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss.Filing
May 13, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale1,575$223.50$352.0K+38.0%Form 4 ↗
May 12, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale459$224.00$102.8K+36.9%Form 4 ↗
May 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale105$232.57$24.4K+31.1%Form 4 ↗
May 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale116$234.09$27.2K+31.1%Form 4 ↗
May 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale80$227.37$18.2K+31.1%Form 4 ↗
May 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale1$229.87$230+31.1%Form 4 ↗
May 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale165$231.87$38.3K+31.1%Form 4 ↗
Apr 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale146$199.97$29.2K+39.6%Form 4 ↗
Apr 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale40$201.24$8,050+39.6%Form 4 ↗
Apr 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale79$202.42$16.0K+39.6%Form 4 ↗
Apr 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale43$202.91$8,725+39.6%Form 4 ↗
Apr 1, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale159$204.26$32.5K+39.6%Form 4 ↗
Mar 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale42$203.57$8,550+42.5%Form 4 ↗
Mar 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale47$197.14$9,266+42.5%Form 4 ↗
Mar 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale204$199.69$40.7K+42.5%Form 4 ↗
Mar 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale41$200.40$8,216+42.5%Form 4 ↗
Mar 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale83$201.65$16.7K+42.5%Form 4 ↗
Mar 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale50$202.54$10.1K+42.5%Form 4 ↗
Feb 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale39$191.00$7,449+47.5%Form 4 ↗
Feb 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale1$192.18$192+47.5%Form 4 ↗
Feb 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale23$195.61$4,499+47.5%Form 4 ↗
Feb 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale381$196.36$74.8K+47.5%Form 4 ↗
Feb 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale23$197.20$4,536+47.5%Form 4 ↗
Jan 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale21$186.59$3,918+52.0%Form 4 ↗
Jan 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale91$187.95$17.1K+52.0%Form 4 ↗
Jan 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale102$188.96$19.3K+52.0%Form 4 ↗
Jan 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale207$190.27$39.4K+52.0%Form 4 ↗
Jan 2, 2026LGND
Ligand Pharmaceuticals Incorporated
Sale46$192.40$8,850+52.0%Form 4 ↗
Dec 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale92$193.86$17.8K+45.9%Form 4 ↗
Dec 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale179$194.76$34.9K+45.9%Form 4 ↗
Dec 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale47$195.80$9,203+45.9%Form 4 ↗
Dec 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale4$196.35$785+45.9%Form 4 ↗
Dec 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale92$197.72$18.2K+45.9%Form 4 ↗
Dec 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale23$199.22$4,582+45.9%Form 4 ↗
Dec 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale30$200.02$6,001+45.9%Form 4 ↗
Nov 3, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale84$189.00$15.9K+51.1%Form 4 ↗
Nov 3, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale49$190.26$9,323+51.1%Form 4 ↗
Nov 3, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale207$191.25$39.6K+51.1%Form 4 ↗
Nov 3, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale127$192.38$24.4K+51.1%Form 4 ↗
Oct 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale24$177.60$4,262+59.6%Form 4 ↗
Oct 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale196$178.41$35.0K+59.6%Form 4 ↗
Oct 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale155$180.01$27.9K+59.6%Form 4 ↗
Oct 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale92$181.18$16.7K+59.6%Form 4 ↗
Sep 2, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale267$161.51$43.1K+70.8%Form 4 ↗
Sep 2, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale115$162.52$18.7K+70.8%Form 4 ↗
Sep 2, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale85$164.25$14.0K+70.8%Form 4 ↗
Aug 1, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale467$131.88$61.6K+111.3%Form 4 ↗
Jul 10, 2025LGND
Ligand Pharmaceuticals Incorporated
Sale934$125.00$116.8K+126.5%Form 4 ↗

Each row links to its Form 4. Since trade compares the stock’s move from the close on the trade date (or the next trading day) to its latest close with the S&P 500 over the same days, adjusted for splits and excluding dividends. It describes the stock, not what the trader made: we don’t know their purchase price, position size or later sales. A dash means the trade isn’t matched to a listed stock, or there is no closing price after it yet.

When several people report on the same filing, we list it under the first one named, so trades by someone usually listed second may be missing here. Information, not investment advice: see the disclaimer.